Vaccines are on the way, but distribution presents herculean ethical and logistical challenges.

The AstraZeneca/Oxford University COVID-19 vaccine has up to 90% efficacy against SARS-CoV-2—and would be easier to distribute than other promising candidates, according to interim results from a Phase 3 vaccine trial.  

On April 5, former BuzzFeed journalist Patrice Peck sent out the first installment of her brand new newsletter, 

Anthony Fauci has endorsed Vermont as “a model for the country” for its robust response and consistently low coronavirus spread.   What sets it apart:

The misuse of antibiotics to treat COVID-19 could accelerate the spread of antimicrobial resistance, 

The antiviral remdesivir should not be used as a treatment for hospitalized COVID-19 patients, the WHO now says, citing a lack of evidence that it improves survival or reduces the need for ventilators, 

COVID-19 has taken more than 250,000 lives in the US—more than strokes, suicides, and car crashes combined in a typical year, 

A controversial new study out of Denmark has found that wearing surgical masks did little to protect wearers from contracting COVID-19—clashing 

It’s been a big month for Loyce Pace.   Last week, she was appointed to President-elect Joe Biden’s COVID-19 advisory board—but as she pointed out on Twitter, “I still very much have a day job”—as president and executive director of Global Health Council. 

This is exciting news. The most robust study yet on COVID-19 immunity has found that it may last for years and perhaps decades.   The study by researchers at the La Jolla Institute of Immunology has not yet been peer reviewed, but it squares with similar findings from…